Back
Outlook Therapeutics, Inc. Stock Price Chart
The Next AI Breakouts Won't Talk Like ChatGPT
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Sell
20
OTLK
Outlook Therapeutics, Inc.
Last Price:
$0.43
Seasonality Move:
-3.7%
7 Day Trial
ALL ACCESS PASS
$
7
This Critical Mineral's Up 122% in the Last 12 Months.
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OTLK is experiencing buying pressure, which is a positive indicator for future bullish movement.
Outlook Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.43 | Sell |
| 20-day SMA: | 0.49 | Sell |
| 50-day SMA: | 1.23 | Sell |
| 200-day SMA: | 1.52 | Sell |
| 8-day EMA: | 0.35 | Buy |
| 20-day EMA: | 0.21 | Buy |
| 50-day EMA: | 0.1 | Buy |
| 200-day EMA: | 0.03 | Buy |
Outlook Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 27.32 | Sell |
| Chaikin Money Flow: | 683451 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.44 - 0.58) | Sell |
| Bollinger Bands (100): | (0.71 - 1.81) | Sell |
Outlook Therapeutics, Inc. Technical Analysis
| Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 26 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Outlook Therapeutics, Inc. Stock
Is Outlook Therapeutics, Inc. Stock a Buy?
-
Outlook Therapeutics, Inc. share price is 0.43 while OTLK 8-day simple moving average is 0.43, which is a Sell signal.
-
The stock price of OTLK is 0.43 while Outlook Therapeutics, Inc. 20-day SMA is 0.49, which makes it a Sell.
-
Outlook Therapeutics, Inc. 50-day simple moving average is 1.23 while OTLK share price is 0.43, making it a Sell technically.
-
OTLK stock price is 0.43 and Outlook Therapeutics, Inc. 200-day simple moving average is 1.52, creating a Sell signal.
OTLK Technical Analysis vs Fundamental Analysis
Sell
20
Outlook Therapeutics, Inc. (OTLK)
is a Sell
Is Outlook Therapeutics, Inc. a Buy or a Sell?
-
Outlook Therapeutics, Inc. stock is rated a SellThe current Outlook Therapeutics, Inc. [OTLK] share price is $0.43. The Score for OTLK is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Outlook Therapeutics, Inc. Stock Info
Market Cap:
27.5M
Price in USD:
0.43
Share Volume:
1.2M
Outlook Therapeutics, Inc. 52-Week Range
52-Week High:
3.39
52-Week Low:
0.38
Sell
20
Outlook Therapeutics, Inc. (OTLK)
is a Sell
Outlook Therapeutics, Inc. Share Price Forecast
-
What is the Outlook Therapeutics, Inc. stock price today?The Outlook Therapeutics, Inc. stock price is 0.43 USD today.
-
Will OTLK stock go up or go down?Outlook Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Outlook Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Outlook Therapeutics, Inc. is overvalued.
Is Outlook Therapeutics, Inc. Stock a Buy?
-
Outlook Therapeutics, Inc. share price is 0.43 while OTLK 8-day exponential moving average is 0.35, which is a Buy signal.
-
The stock price of OTLK is 0.43 while Outlook Therapeutics, Inc. 20-day EMA is 0.21, which makes it a Buy.
-
Outlook Therapeutics, Inc. 50-day exponential moving average is 0.10 while OTLK share price is 0.43, making it a Buy technically.
-
OTLK stock price is 0.43 and Outlook Therapeutics, Inc. 200-day simple moving average is 0.03, creating a Buy signal.
Fundamental Analysis of Outlook Therapeutics, Inc.
Is Outlook Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.17 per share, and an increase next year of $0.26 per share.
Technical Analysis of Outlook Therapeutics, Inc.
Should I short Outlook Therapeutics, Inc. stock?
-
OTLK Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Outlook Therapeutics, Inc. is a Buy
-
Outlook Therapeutics, Inc. Relative Strength Index (RSI) is 27.32, which suggest Outlook Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Outlook Therapeutics, Inc. is (0.44 - 0.58), which suggest Outlook Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Outlook Therapeutics, Inc. is (0.71 - 1.81), which suggest Outlook Therapeutics, Inc. is a Sell
* Outlook Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.